aTyr Pharma | LIFE - Ebit

Stock Price
0.87
Daily Change
-0.09 -8.90%
Monthly
17.24%
Yearly
-77.80%
Q1 Forecast
0.86

aTyr Pharma reported $-226.49K in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Ardelyx USD 7.12M 19.62M Sep/2025
aTyr Pharma USD -226.49K 140.85K Sep/2025
Biogen USD 659.6M 157M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD -7.89M 536K Sep/2025
CSL USD 2.75B 1.35B Dec/2024
Galapagos EUR -41.67M 15.35M Sep/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
Grifols EUR 411.56M 15.51M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
United Therapeutics USD 389.3M 112.4M Sep/2025